Phase 4 Tuberculosis Trial, Recruiting (NCT06484530)

Phase 4 Tuberculosis Trial, Recruiting NCT06484530 Sponsor: Mahidol University Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT06484530 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 80 years old.
You have been recently diagnosed with tuberculosis (TB), whether it affects the lungs or another part of the body.
You are receiving the standard TB treatment medications (following one of two standard treatment plans).
You are willing to take part in the research.

Who may not be able to join:

You are living with HIV.
You have serious liver disease that doctors rate as moderately or severely impaired (confirm with trial site).
You have an ongoing, untreated liver condition such as hepatitis B, hepatitis C, or liver damage caused by alcohol use.
Your liver function blood test results are above certain levels, meaning your liver may not be working as it should (confirm with trial site for specific values).
You have been diagnosed with cancer.
You have had an allergic reaction to a substance called N-acetylcysteine (NAC) in the past.
You are currently pregnant or breastfeeding.
You have certain serious long-term health conditions, such as advanced kidney disease, chronic heart failure, or severe lung diseases such as COPD or bronchiectasis.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Supot Nimanong, Mahidol University

Phone: 66954408520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06484530

Sponsor: Mahidol University

Phase: Phase 4

Status: Recruiting

Condition: Tuberculosis

Trial contact: 66954408520

More information: https://clinicaltrials.gov/study/NCT06484530

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 80 years old.
You have been recently diagnosed with tuberculosis (TB), whether it affects the lungs or another part of the body.
You are receiving the standard TB treatment medications (following one of two standard treatment plans).
You are willing to take part in the research.

Who may not be able to join:

You are living with HIV.
You have serious liver disease that doctors rate as moderately or severely impaired (confirm with trial site).
You have an ongoing, untreated liver condition such as hepatitis B, hepatitis C, or liver damage caused by alcohol use.
Your liver function blood test results are above certain levels, meaning your liver may not be working as it should (confirm with trial site for specific values).
You have been diagnosed with cancer.
You have had an allergic reaction to a substance called N-acetylcysteine (NAC) in the past.
You are currently pregnant or breastfeeding.
You have certain serious long-term health conditions, such as advanced kidney disease, chronic heart failure, or severe lung diseases such as COPD or bronchiectasis.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Mahidol University

Registry

ClinicalTrials.gov

Start date

12 March 2024

Est. completion

18 September 2024

Where this trial is recruiting

🇹🇭 Thailand

Primary endpoints

Prevalence of hepatitis at 8 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov